Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03996096Completed
Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors.
Chronic Myeloid LeukemiaTyrosine Kinase InhibitorWithdrawal Syndrome
PrincipalinvestigatorStart date: 2019-04-23

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveTyrosine Kinase Inhibitors
Similarity Score20%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

K A Bradstock), Dr.

Westmead Hospital

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

J Szer, Dr.

Royal Melbourne Hospital, Parkville, Australia

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

E Gluckman, Dr.

Hopital St Louis, Paris, France

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

J Rowe, Dr.

Rambam Medical Center, Haifa, Israel

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

G Lambertenghi-Deliliers, Dr.

Padiglione G Marcora, Ospedale Maggiore di Milano, Italy

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

T Ruutu, Dr.

Helsinki University CT. Rentral Hospital, Finland

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03996096PrincipalInvestigator

Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors.

Chronic Myeloid LeukemiaTyrosine Kinase InhibitorWithdrawal Syndrome
Completed

All 1 trials loaded